Upload
Featured Recent Articles Topics Login Upload

Search Results for '(glp-1)'

(glp-1) published presentations and documents on DocSlides.

“Weighing” in on GLP-1 Receptor Agonists
“Weighing” in on GLP-1 Receptor Agonists
by priscilla
for People With HIV. Suman Srinivasa, MD, MS. Mass...
A Clinical Approach Utilizing GLP-1 RAs
A Clinical Approach Utilizing GLP-1 RAs
by udeline
Diabetes Management . for the Cardiologist. Confid...
Insulin/GLP-1 Agonist Combinations
Insulin/GLP-1 Agonist Combinations
by calandra-battersby
Program Overview. Pathophysiology of Hyperglycemi...
Chad Christianson Jason Watts Katherine Yahvah and Michael Williams
Chad Christianson Jason Watts Katherine Yahvah and Michael Williams
by mackenzie
OVERVIEW 4080120160200240280320360400440480Analyte...
BTUSPFOUFSPMPHZ3FTFBSDIBOE1SBDU
BTUSPFOUFSPMPHZ3FTFBSDIBOE1SBDU
by audrey
)JOEBXJ 7PMVNF\r"SUJ...
GLP-1/Glucagon Dual Receptor Agonist ALT-801 is Superior to Semaglutide in Improving NASH Endpoint
GLP-1/Glucagon Dual Receptor Agonist ALT-801 is Superior to Semaglutide in Improving NASH Endpoint
by sophie
Biopsy-Confirmed DIO Mouse Model. JJ Nestor. 1. , ...
Psychiatry Meeting 24 th
Psychiatry Meeting 24 th
by layla
November 2016. Andrew Gallagher. Consultant Physic...
Current Therapy in Type 2 Diabetes:
Current Therapy in Type 2 Diabetes:
by Dragonlord
What Follows Metformin? . James R. Gavin III, MD, ...
F. Hosseinpanah Obesity Research Center
F. Hosseinpanah Obesity Research Center
by Outlawking
Research Institute for Endocrine sciences. Shahid....
Incretin -based therapies
Incretin -based therapies
by SoulfulDreamer
Part I. F. . Hosseinpanah. Obesity Research Center...
Genotoxicity and Industry:
Genotoxicity and Industry:
by deena
Utilizing genetic toxicity assays to . support pha...
Introduction to the GLPTN Program
Introduction to the GLPTN Program
by jocelyn
Network Overview. TCPI Program. The Transforming ....
A conserved dorsomedial hypothalamic population mediates leptin’s control of body weight
A conserved dorsomedial hypothalamic population mediates leptin’s control of body weight
by barbara
Alan C. Rupp. 1. , Abigail J. Tomlinson. 1. , Alis...
Shifting Paradigms in the Selection of
Shifting Paradigms in the Selection of
by alyssa
Antidiabetes. Medications:. Cardiovascular Benefi...
Figure Figure. Laboratory findings of hemorrhagic diathesis in an 18-year-old Somalian refugee to G
Figure Figure. Laboratory findings of hemorrhagic diathesis in an 18-year-old Somalian refugee to G
by yvonne
Keller C, Zumblick M, Streubel K, Eickmann M, Mül...
Oral hypoglycemics Jennifer R Marks, MD
Oral hypoglycemics Jennifer R Marks, MD
by finley
Oral hypoglycemics. Factors to consider:. Cost. Av...
TheemergingroleofFOXOtranscriptionfactorsinpancreaticDominiqueAGlauser
TheemergingroleofFOXOtranscriptionfactorsinpancreaticDominiqueAGlauser
by maisie
ForkheadbRZQORDGHGIURPLRVFLHQWLILFDFRPDW0YLDIUHHDF...
Overview of CVM Overview of CVM
Overview of CVM Overview of CVM
by della
1Overview of Overview of Clinical Investigator CIC...
Insulin and Incretins:
Insulin and Incretins:
by liane-varnes
Insulin and Incretins: the perfect Partnership? S...
Updates Abound Introduction
Updates Abound Introduction
by sherrill-nordquist
GLP-1 RAs in Combination With Basal Insulin Appro...
The Influence of Type 2 Diabetes on Cardiovascular Disease
The Influence of Type 2 Diabetes on Cardiovascular Disease
by conchita-marotz
and Glycemic Treatment Options. Rocky . Mountain/...
GLP-1 Agonist Clinical Case Challenge: Intensifying Therapy and Improving Management of T2D
GLP-1 Agonist Clinical Case Challenge: Intensifying Therapy and Improving Management of T2D
by stefany-barnette
Program Goal. Case Presentation: Diane. Case Pres...
NEUROENDOCRINE APPETITE REGULATION: NOVEL WEIGHT LOSS STRATEGIES
NEUROENDOCRINE APPETITE REGULATION: NOVEL WEIGHT LOSS STRATEGIES
by alexa-scheidler
Prevalence of Adult Obesity: 2000 to Present. Cli...
SGLT-2 Inhibitor with Incretins
SGLT-2 Inhibitor with Incretins
by pamella-moone
Add on to insulin. EFFICACY AND TOLERABILITY. OF ...
Psychiatry Meeting
Psychiatry Meeting
by myesha-ticknor
24. th. November 2016. Andrew Gallagher. Consult...
Global Learning
Global Learning
by pasty-toler
T. ask – . -Please go through the slides and fo...
Modelling of GLP-1 and its analogues effect on food digesti
Modelling of GLP-1 and its analogues effect on food digesti
by alida-meadow
Veronika Voronova, Kirill . Zhudenkov. , Kirill ....
Current Status of Incretin Based
Current Status of Incretin Based
by min-jolicoeur
Therapies in Type 2 Diabetes. DR.M.Mukhyaprana. ...
A A partnership between Rotary clubs and CoEd
A A partnership between Rotary clubs and CoEd
by olivia-moreira
to promote literacy in Guatemala. 449 . Rotary . ...
ABLEOF ONTENTSENDURE POGRAMANDEETINGOAL……………&
ABLEOF ONTENTSENDURE POGRAMANDEETINGOAL……………&
by mitsue-stanley
OTE……………………...
Report To Work …………………...…
Report To Work …………………...…
by pasty-toler
January 4th Late Registration ………&...
Additional Notes:
Additional Notes:
by phoebe-click
————————&#...
SURREAL SPACES
SURREAL SPACES
by briana-ranney
€€€€€€ €€&...
TABLE OF CONTENTS
TABLE OF CONTENTS
by mitsue-stanley
Abstract …………………...
Selection and Preparation of Music
Selection and Preparation of Music
by stefany-barnette
……………………&#...
\r\r\f \n\t\b 
\r\r\f \n\t\b 
by alida-meadow
“...
A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy
A Selective Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiomyopathy
by caleb954
James L. Januzzi Jr, . MD. a. , Javed Butler, MD, ...
DRUG DEVELOPEMENT Examples of antidiabetic drugs
DRUG DEVELOPEMENT Examples of antidiabetic drugs
by fauna
The . oldest . oral antidiabetic drugs active agai...
Practical Use of Glucagon-Like Peptide-1 Receptor Agonist Therapy in P
Practical Use of Glucagon-Like Peptide-1 Receptor Agonist Therapy in P
by tatyana-admore
148 The glucagon-like peptide-1 (GLP-1) receptor a...
Kenneth B. Margulies, M.D
Kenneth B. Margulies, M.D
by mitsue-stanley
.. On behalf of the . NHLBI Heart Failure Clinica...